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eturn to Sender
ospital Readmission
fter Percutaneous
oronary Intervention*
ean J. Kereiakes, MD
incinnati, Ohio
ercutaneous coronary intervention (PCI) plays a pivotal role
n the therapeutic management strategies for patients with
ither acute or nonacute coronary artery disease syndromes.
hen legislation enacted in 1983 replaced cost-based payment
or hospital days and services with a set payment per admission
ased on the patient’s diagnosis-related group (DRG), the goal
as to encourage more efficient care and shorter hospital
engths of stay. Concerns were acknowledged that this reim-
ursement strategy might inadvertently provide incentive for
remature hospital discharge for the index hospitalization
nd/or the “unbundling” of services in order to receive separate,
dditional payments for what could have been a single clinical
pisode. Thus, an unintended consequence of the DRG
ayment scheme could be an increase in rehospitalization rates.
fter more than 2 decades, policy makers are now focused on
ates of rehospitalization in an effort to improve quality of care
nd to reduce health care costs. Although considerable data are
vailable regarding rehospitalization attributable to specific
onditions, especially heart failure, very limited information is
vailable regarding the broader scope of diseases and processes
hat influence the frequency and patterns of rehospitalization.
See page 903
In this context, Curtis et al. (1) provide a timely and
ntriguing analysis of PCI practice in the U.S. in this issue of
he Journal. In a retrospective cohort study, they analyzed
edicare fee-for-service administrative claims from a large,
ontemporary PCI population and conclude that approxi-
ately 1 in 7 (14.6%) Medicare patients who undergo PCI are
ehospitalized within 30 days of the index procedure. Although
eadmission rates varied widely across hospitals, patients who
ere readmitted were almost 6 times more likely to die. How
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.t
From the Christ Hospital Heart and Vascular Center/The Carl and Edyth Lindner
enter for Research and Education, Christ Hospital, Cincinnati, Ohio.hould we interpret these observations, and what caveats
hould be applied?
First, the outcome of interest analyzed is all-cause read-
ission after PCI. Although most relevant from a patient
tandpoint, this variable may introduce “noise,” particularly
n patient cohorts with multiple comorbidities. Further
etermination of a specific cardiovascular causality or rela-
ionship to the index PCI procedure may be difficult to
djudicate from the administrative claims-made database
nalyzed. Second, the 14.6% incidence of rehospitalization
ithin 30 days after PCI requires closer examination from
everal perspectives. Although this figure appears to be
ignificantly less than the 19.6% 30-day readmission rate
eported using fee-for-service administrative claims from
n unselected global cohort of almost 12 million Medi-
are beneficiaries, this difference is likely explained by the
arked heterogeneity of Medicare patients, as well as the
ikelihood that Medicare patients who undergo PCI are
ounger and healthier than the overall Medicare population.
ndeed, risk-averse utilization of invasive procedures (the
treatment risk paradox”) has previously been documented
3). Third, by restricting their analyses to hospitals that
erformed 50 PCIs on Medicare fee-for-service patients,
he authors may have, to at least some degree, “volume
redentialed” the hospitals included. As hospital procedural
olume is a significant determinant of outcomes after PCI
4), this somewhat arbitrary cut point for exclusion may
ave influenced the observed readmission rate. It should be
cknowledged that Medicare fee-for-service represents ap-
roximately 50% to 60% of all PCI volume in the U.S. and
hus not the actual total hospital PCI volume. The exclusion
f lower-volume centers was likely chosen in an attempt to
lter out hospitals that only performed primary PCI for
atients with ST-segment elevation myocardial infarction
STEMI), a group more vulnerable to readmission. In
ddition, the minimal volume threshold for inclusion should
rovide a more stable estimate of readmission rates at
ospitals performing PCI. Although this exclusion applied
o only 6,923 patients, the expected result would be a lower
eadmission rate, particularly because the authors identified
cute myocardial infarction as a predictor of subsequent
arly rehospitalization. Furthermore, a statistically signifi-
ant but clinically quite modest difference in readmission
ates by hospital PCI volume strata was observed. Finally,
o data are provided on the influence of physician PCI
olume, an established determinant of PCI outcomes (5), on
ubsequent hospital readmission rates.
Fourth, although readmission within 30 days was signifi-
antly more frequent in patients who had myocardial infarction
n their index hospitalization, stratification by type of infarc-
ion is not provided. It must be acknowledged that the
nternational Classification of Diseases-Ninth Revision-
linical Modification codes in administrative data do not
ccurately distinguish between STEMI and non-STEMI
ypes of infarction (6). This limitation is unfortunate, as further
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September 1, 2009:908–10 Return to Sendertratification by infarct type may have provided useful insight
nto PCI practice strategy and the role of planned readmission
or “staged” PCI procedures. Intuitively, readmission for a
taged PCI procedure would be more likely to occur after
TEMI compared with non-STEMI infarction events. In-
eed, multivessel (vs. culprit vessel only) PCI has been advo-
ated for the treatment of non-STEMI syndromes (7,8),
hereas this practice is not recommended during primary PCI
or STEMI (9). The availability of more robust clinical
nformation with which to complement the administrative
laims-made data might have provided insights into the
elative frequency of readmission by infarct type. Such data
ay also help identify the reasons prompting readmission, as
ell as its variable occurrence. For example, it has been
stimated that 10% of rehospitalizations are planned (2). In
his regard, it is noteworthy that 27.5% of readmissions were
ssociated with an additional revascularization procedure,
hich was PCI in 94% of cases (1). Interestingly, fewer than
0% of these readmissions were associated with an acute
ardiovascular condition (myocardial infarction, unstable an-
ina, arrhythmia, or heart failure), and the majority were
scribed to chronic ischemic heart disease. The most common
ndex surgical procedure associated with subsequent rehospi-
alization in Medicare patients is cardiac stent placement, and
he most frequent reason for rehospitalization after stent
eployment is the placement of another cardiac stent (2).
lthough clinical practice guidelines for PCI acknowledge
pecific scenarios wherein the staging of PCI procedures may
e reasonable (10), the present study raises questions regarding
he more systematic utilization of this practice. Even in the
ost complex of clinical scenarios involving multivessel PCI
or 3 vessels and/or left main coronary artery disease, in which
n average of 4.6 stents per patient was deployed, staging of
CI procedures was required in only 14% of cases (11).
lthough data on the number of stents deployed per patient
re not provided by Curtis et al. (1), the assumed lesser degree
f anatomic complexity in the current Medicare cohort raises
oncern regarding procedural staging for nonclinical indica-
ions, such as reimbursement. To this point, the fixed-rate
RG-based payment does not provide incremental reimburse-
ent in cases requiring multiple stent deployment. This
imitation is particularly pertinent in the era of drug-eluting
tents due to the relatively high unit cost ($2,000) associated
ith these devices. The practice of unbundling services in order
o access incremental reimbursement is suggested by the
eports of both Jencks et al. (2) and Curtis et al. (1). Indeed, in
omparing the top and bottom deciles for hospital readmission
Fig. 2 of Curtis et al. [1]), the greatest relative increment is
bserved in that portion of readmissions associated with a
evascularization procedure (PCI).
Fifth, what are the reasons for variability in readmission, and
hat can be done to further address this issue? Curtis et al. (1)
dentify statistically significant but clinically modest variability
n readmission on the basis of hospital profit, teaching, and
pecialty status. Wider variability in the frequency of hospital
eadmission by geography was observed. Patient demographic tactors that were associated with readmission included increas-
ng age, female sex, and comorbidities such as diabetes, heart
ailure, renal insufficiency, and known prior ischemic heart
isease. Acknowledging the complexity and diversity of factors
hat contribute to hospital readmission, the 2008 MedPAC
eport recommendation that “risk-adjusted” rehospitalization
ates be published within 2 years is concerning (12). The
triking variability in this measure across various patient pop-
lations in addition to the challenge of appropriate and
ccurate risk adjustment is evident from the rates of hospital
eadmission to 30 days after PCI in commercially insured
opulations (Anthem Blue Cross/Blue Shield of Ohio;
nitedHealthcare U.S. commercial cohort) during 2008.
verage readmission rates by payor ranged between 5.6% and
0.8%, with wide variability by market and facility. These
eadmission rates appear appreciably lower than those reported
y either Curtis et al. (1) or Jencks et al. (2) and may be
xplained by the younger average age (55.3 to 57.0 years) of the
atient cohorts analyzed, as well as a lower prevalence of
omorbidities (R.F. Shonk, B.C. Malinowski, personal com-
unications, April 28, 2009). Of note, the National Quality
orum has adopted 2 measures of hospital performance based
n the rate of rehospitalization (13), and the Centers for
edicare and Medicaid Services (CMS) has suggested making
ehospitalization rate a measure for value-based hospital pay-
ent (14). In an attempt to create shared incentives to provide
ore efficient and coordinated care between the inpatient and
utpatient domains, MedPac has gone so far as to recommend
hat hospitals be allowed to financially reward physicians for
elping to reduce readmissions and that CMS establish a pilot
rogram to test bundling payments for an episode of care
xtending beyond discharge for select conditions (15).
The need for enhanced coordination of care is suggested
y the fact that no physician encounter occurred between
he time of hospital discharge and subsequent readmission
n more than one-half of all Medicare patients discharged
ith a medical condition who required rehospitalization (2).
n this regard, controlled studies have demonstrated that
pecific interventions at the time of hospital discharge can
educe the rate of subsequent rehospitalization (16,17). The
ost definitive evidence comes from studies evaluating the
oordination of care for congestive heart failure. It may be
ppropriate for the CMS pay-for-performance program to
ncorporate indicators that reflect the coordination of care
fter discharge, such as the reconciliation of medications
oth on discharge and again after home arrival, the arrange-
ent of timely follow-up, and the provision of timely and
omplete medical records regarding the hospital course to
he outpatient provider.
Should hospital readmission after PCI be adopted as a
uality measure for the performance of PCI? Benchmarking
quality performance measure without firm understanding
f the multiple and diverse factors (patient, procedural,
ospital, practice process, and so on) that contribute to its
ccurrence is challenging and potentially unreliable. Fur-
hermore, the integration of inpatient and outpatient do-
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Return to Sender September 1, 2009:908–10ains required to efficiently effect process change, and thus
mpact readmission rates, is tantamount to the creation of
rograms for disease management across multiple disease
rocesses and procedures. The seamless integration of
nformation technology (hardware, software, personnel for
ata management) necessary to provide continuous quality
mprovement is logistically formidable and costly. Indeed,
he very low levels of adoption (10%) of electronic health
ecords by U.S. hospitals suggest that organizations such as
edPAC, CMS, and National Quality Forum should first
houghtfully provide incentives for these changes in an effort
o enhance the integration and quality of patient care (18).
The current proposal is to develop readmission bench-
arks for specific conditions on the basis of a weighted
verage of all related DRGs that is risk-adjusted for patient
everity of illness and case type (19). The readmission
enchmark would include all readmissions that result from
omplications or related conditions, but would exclude
eadmissions deemed not to be potentially preventable
including planned readmissions). When patients are read-
itted to a hospital different from their index admission
ospital, the readmission counts toward the index hospital
ate. Beginning in October 2012, hospitals with readmission
ates above the 75th percentile for selected conditions would
e subject to a 20% payment withhold on a DRG-by-DRG
asis based on the prior year’s performance. Payment
ithholds could be reimbursed if the patients involved do
ot have “preventable” readmissions within 30 days of
ischarge. Beginning in October 2014, acute hospital ser-
ices and post-acute care services occurring or initiated
ithin 30 days of hospital discharge will be paid through a
undled payment. The first phase of this payment bundling
olicy will apply to admissions for conditions accounting for
he top 20% of post-acute care spending.
The alignment of incentives among doctors and hospitals
o create better integrated systems for care is a desirable
bjective of these policy changes and will likely require a
aiver or revision of current law, which precludes collabo-
ation in collective bargaining between these entities. Fur-
hermore, the ultimate success (quality and cost) of the
ntegration strategy may require that patients who are
urrently free to migrate between hospital systems stay
ithin their index system for care.
Readmission after PCI is but 1 piece from the larger
uzzle of health care process reform. Although a 30-day
warranty” after hospital discharge is an admirable aspi-
ation, the incentives and tools required to successfully
ccomplish process improvement must first be put into
lace.
eprint requests and correspondence: Dr. Dean J. Kereiakes,
he Lindner Research Center, 2123 Auburn Avenue, Suite 424,
incinnati, Ohio 45219. E-mail: lindner@fuse.net.
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